MdxHealth Company
MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.
Industry:
Molecular
Headquarters:
Irvine, California, United States
Founded Date:
2003-01-01
Employees Number:
51-100
Funding Status:
IPO
Acquisitions Number:
2
Investors Number:
8
Total Funding:
$92,375,489.00
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-08-02
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership